| |
NACRT (n = 17)
|
Non-NACRT (n = 11)
|
P-value
|
|---|
|
Age(mean ± SD)
|
59.9 ± 7.9
|
63.6 ± 10.4
|
0.287*1
|
|
Gender(male/female)
|
8/9
|
6/5
|
1.000*2
|
|
Operative procedures PD/DP/TP
|
13/3/1
|
10/1/0
|
1.000*2
|
|
Portal vein resection
|
70.6% (12/17)
|
63.6% (7/11)
|
1.000*2
|
|
cT(1/2/3/4)
|
0/0/17/0
|
0/0/11/0
|
1.000*2
|
|
cN(0/1)
|
11/6
|
6/5
|
0.701*2
|
|
pT(0/1/2/3/4)
|
0/1/16/0
|
0/0/11/0
|
1.000*2
|
|
pN(0/1)
|
13/4
|
5/6
|
0.125*2
|
|
Histological classification G1-2/G3/ungradeable
|
11/5/1
|
8/3/0
|
1.000*2
|
|
Residual tumor R0/R1-2
|
17/0
|
9/2
|
0.146*2
|
|
Tumor destruction (Evan’s criteria)I/IIa/IIb/III/IV
|
1/7/7/2/0
| | |
- SD: standard deviation; PD: pancreatoducdenectomy; DP: distal pancreatectomy; TP total pancreatectomy. *1: Unpaired t-test. *2: Fisher’s exact test.
